You are here

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Tucson, Arizona, 85404 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Acute Myeloid Leukemia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Treated by Mylotarg

- Provide ICF

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Treated by Mylotarg

- Provide ICF

NCT00161668
Pfizer
Completed
Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Acute Myeloid Leukemia
NCT02038777
All Genders
20+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now